Table 1.
Sample type and clinical features | Experiment type (cases)
|
|
---|---|---|
qRT-PCR | IHC | |
Prostate cancer | 26 | 98 |
Mean age (years) | ||
<60 | 20 | 62 |
≥60 | 6 | 36 |
Serum PSA levels (ng/mL) | ||
<4 | 5 | 16 |
≥4 | 21 | 82 |
Gleason score | ||
<8 | 24 | 87 |
≥8 | 2 | 11 |
Clinical stage | ||
<T2A | 17 | 59 |
≥T2A | 9 | 39 |
Metastasis | 0 | 5 |
Adjacent benign prostate tissue | 26 | 26 |
Abbreviations: qRT-PCR, quantitative reverse transcription polymerase chain reaction; IHC, immunohistochemistry; PSA, prostate-specific antigen.